Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - India
Summary - Insulin Lispro Biphasic Injection [Inj. Insulin Lispro 50% + Insulin Lispro Protamine Suspension 50% (R-Dna Origin)] 10.
Deadline - Aug 07, 2025
GT reference number - 113974290
Product classification - Medicinal products for the alimentary tract and metabolism
Address - India
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 113974290
Document Type - Tender Notices
Description - notice_title: Insulin Lispro Biphasic Injection [Inj. Insulin Lispro 50% + Insulin Lispro Protamine Suspension 50% (R-Dna Origin)] 10.local title:: INSULIN LISPRO BIPHASIC INJECTION [Inj. Insulin Lispro 50% + Insulin Lispro Protamine Suspension 50% ( R-DNA origin)] 10.Contract Type: : Supply
Gt Ref Id - 113974290
Deadline - Aug 07, 2025
Similar Tenders :
|
Summary:
|
|
Summary:
|
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
